Journals

Human cytomegalovirus (CMV) is a member of the family Herpesviridae. This virus can remain dormant in the body over a long period after…

This informative podcast spotlights the current treatment landscape of hypertrophic cardiomyopathy (HCM), detailing typical diagnosis and outlining the use of echocardiography for obstructive HCM. Featured on this episode is Fabian Knebel, Senior Consultant for the Department of Cardiology and Angiology, Charité–Universitätsmedizin, Berlin, and Head of the Cardiology Department, Sana Klinikum Lichtenberg, Berlin, Germany.

We are proud to present the latest issue of EMJ Urology! Included in this edition are the most recent developments in this specialty. You can find interviews with leading experts alongside peer-reviewed articles and the scientific highlights from the annual European Association of Urology (EAU) 2023 meeting which took place in Milan, Italy. 

This article shines a light on the treatment of venous thromboembolism (VTE), a condition with higher rates of morbidity and mortality than both breast and prostate cancer.

Welcome to the latest issue of EMJ Radiology! We are proud to share with you research, case reports, and features that highlight key topics in the field.

Cholestatic liver diseases include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and progressive familial intrahepatic cholestasis (PFIC). In all of these conditions, cholestatic itch is a major symptom that can severely and chronically impact a person’s quality of life (QoL).

We are excited to share our first 2023 issue of EMJ, which includes content across medical disciplines, with a mini-focus on paediatric healthcare.

Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.